fbpx
Latest News

U.S. Military Gets a Quicker Access to Migraine Relief Technology

Moving over lengthy approval process, a new partnership between QB Medical Inc. and CEFALY Technology has provided the U.S. military quicker access to migraine relief.

This collaboration is giving wearable medical devices to healthcare providers. That grants immediate relief from headaches to active military and their dependents.

The partnership between QB Medical Inc. and CEFALY Technology

Jennifer Trainor-McDermott is CEO of CEFALY Technology. She said that her team is excited to partner up with QB Medical and help active military and their dependents in finding more easy methods of pain relief.

According to her, it’s an honor to provide these brave men and women fewer hurdles on their path to recovery. Before this collaboration, active military and their dependents had to go through a lengthy approval process for obtaining a device through TRICARE.

TRICARE is a health care program for military service members, retirees, and their families. From start-to-end, a uniformed service member could be having several weeks of potential migraines before he receives his CEFALY device.

Related: FDA Approves New Medicine for Acute Treatment of Migraine

But after the partnership between QB Medical Inc. and CEFALY Technology, health caregivers will be capable of having inventory on hand to help patients during their scheduled appointments.

This is a major improvement that will be felt immediately among soldiers looking for help to treat migraine headaches, stated said Shawn Nelson, CEO with QB Medical, Inc.  Nelson has completed his service as healthcare practitioner for the US Navy and later started his SDVOSB – Service-Disabled Veteran-Owned Small Business.

According to him, the CEFALY device has proven to be helpful to soldiers, especially those who have to be careful about what medicines they consume or who cannot simply tolerate more drugs in their system.

CEFALY device for migraine relief

The CEFALY device is the first medical technology of its kind that is FDA-cleared for the treatment of migraine headaches. It is a non-invasive device that is placed on the forehead.

The device uses two different programs, PREVENT and ACUTE, to stimulate and desensitize the Trigeminal nerve. That is the area identified as a center for migraine pain by research. As CEFALY isn’t a drug, it can be used as a standalone option, or along with an existing drug.

The patients who consistently use the device show a reduction in migraine days and the intake of migraine drugs. According to an estimation by the American Migraine Foundation, nearly one-third of returning soldiers suffer from migraine pain in the first months after coming home.

But still, studies repeatedly show that this condition is mostly underdiagnosed. Headache is one of the most common symptoms after traumatic brain injury (TBI).

The Defense and Veterans Brain Injury Center has the responsibility to track TBI data in the U.S. military. According to it, in 2017, there were over 15,000 active-duty soldiers with TBI. And up till now, for 2018, over 3,600 cases of TBI have been reports after the first quarter.

About CEFALY Technology

CEFALY Technology is a Belgium-based company, with US offices based in Connecticut and Wilton. It specializes in electronics for medical purposes. It has developed external cranial stimulation technology for uses in the field of neurology; especially for treating migraines.

About QB Medical

QB Medical, Inc. is a medical supply distributor founded in 2005 and located in Chula Vista, Ca.  It provides services to more than 100 government-funded medical centers. And is passionate about discovering the most efficient medical products for the military service members, government healthcare providers, and patients.

Hannah Cleese

An author at Ask Health News, Hannah has good experience in Health And Physical Education and delivers her research work to entertain readers. Her words reflect creativity and intellect as she succeeds in shaping them into interesting articles for readers. Email: cleese@askhealthnews.com

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close

Adblock Detected

Please consider supporting us by disabling your ad blocker